Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Roest

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Stroke|November 25, 2003
Editorial comment-- genetic make-up for increased PAI-1 expression protects against strokeMark Roest, Jan Dirk Banga
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 25, 2020
Current methods of measuring platelet activity: pros and consHassan Mansouritorghabeh, Bas de Laat, Mark Roest
Handbook of Experimental Pharmacology|August 25, 2012
Platelet interaction with the vessel wallPhilip G de Groot, Rolf T Urbanus, Mark Roest
American Journal of Ophthalmology|January 5, 2005
Trace microalbuminuria in inflammatory cystoid macular edemaBram van Kooij, Rob Fijnheer, Mark Roest, et al.
Plos One|March 3, 2021
Long-term platelet priming after glycoprotein VI stimulation in comparison to Protease-Activating Receptor (PAR) stimulationJinmi Zou, Jiayu Wu, Mark Roest, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|May 9, 2013
Platelet Activation Test in Unprocessed Blood (Pac-t-UB) to Monitor Platelet Concentrates and Whole Blood of Thrombocytopenic PatientsMark Roest, Thijs C van Holten, Ger-Jan Fleurke, et al.
Thrombosis Research|October 15, 2018
The anticoagulant effect of dabigatran is reflected in the lag time and time-to-peak, but not in the endogenous thrombin potential or peak, of thrombin generationSaartje Bloemen, Suzanne Zwaveling, Jonathan Douxfils, et al.
Thrombosis and Haemostasis|July 21, 2017
Interdependence between osteoprotegerin and active von Willebrand factor in long-term cardiovascular mortality prediction in patients undergoing percutaneous coronary interventionJolanta Siller-Matula, Irene M Lang, Christian Schoergenhofer, et al.
Thrombosis and Haemostasis|March 20, 2021
Added Value of Blood Cells in Thrombin Generation TestingJun Wan, Joke Konings, Bas de Laat, et al.
Biomarker Insights|May 5, 2017
Soluble P-selectin as a Biomarker for Infection and Survival in Patients With a Systemic Inflammatory Response Syndrome on the Intensive Care UnitIrene T Schrijver, Hans Kemperman, Mark Roest, et al.
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Stroke|November 25, 2003
Editorial comment-- genetic make-up for increased PAI-1 expression protects against strokeMark Roest, Jan Dirk Banga
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|August 25, 2020
Current methods of measuring platelet activity: pros and consHassan Mansouritorghabeh, Bas de Laat, Mark Roest
Handbook of Experimental Pharmacology|August 25, 2012
Platelet interaction with the vessel wallPhilip G de Groot, Rolf T Urbanus, Mark Roest
American Journal of Ophthalmology|January 5, 2005
Trace microalbuminuria in inflammatory cystoid macular edemaBram van Kooij, Rob Fijnheer, Mark Roest, et al.
Plos One|March 3, 2021
Long-term platelet priming after glycoprotein VI stimulation in comparison to Protease-Activating Receptor (PAR) stimulationJinmi Zou, Jiayu Wu, Mark Roest, et al.
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|May 9, 2013
Platelet Activation Test in Unprocessed Blood (Pac-t-UB) to Monitor Platelet Concentrates and Whole Blood of Thrombocytopenic PatientsMark Roest, Thijs C van Holten, Ger-Jan Fleurke, et al.
Thrombosis Research|October 15, 2018
The anticoagulant effect of dabigatran is reflected in the lag time and time-to-peak, but not in the endogenous thrombin potential or peak, of thrombin generationSaartje Bloemen, Suzanne Zwaveling, Jonathan Douxfils, et al.
Thrombosis and Haemostasis|July 21, 2017
Interdependence between osteoprotegerin and active von Willebrand factor in long-term cardiovascular mortality prediction in patients undergoing percutaneous coronary interventionJolanta Siller-Matula, Irene M Lang, Christian Schoergenhofer, et al.
Thrombosis and Haemostasis|March 20, 2021
Added Value of Blood Cells in Thrombin Generation TestingJun Wan, Joke Konings, Bas de Laat, et al.
Biomarker Insights|May 5, 2017
Soluble P-selectin as a Biomarker for Infection and Survival in Patients With a Systemic Inflammatory Response Syndrome on the Intensive Care UnitIrene T Schrijver, Hans Kemperman, Mark Roest, et al.
Pageof 15